Key News
1. Li Qiang: Actively explore the linkage between futures and spot markets to enhance the international influence of commodity price formation mechanisms.
2. Shanghai Stock Exchange: Changxin Technology Group Co., Ltd.'s IPO review status has changed to "submitted for registration."
3. Hong Kong Monetary Authority: Three new regulatory measures have been added for mainland investors' investment accounts, with account opening verification traced back to January 2023.
Individual Stock News
1. Luxshare Precision was fined 900,000 yuan by the State Administration for Market Regulation for failing to declare its concentration of undertakings in advance as required by law.
2. Loongson Technology: Plans to raise no more than 2.3 billion yuan through private placement for R&D and industrialization projects of information chips based on Xnm technology.
3. A subsidiary of CATL has officially begun cooperation negotiations with senior executives of Zhang Xue Locomotive.
4. Xiongtou Shares: The concept of Tao (τ) law is not related to the company's main business.
5. Yunnan Germanium: The price of indium phosphide wafers has recently increased.
6. Changxin Technology: Subsidiary plans to purchase computing servers for no more than 3 billion yuan.
7. Kweichow Moutai: Share repurchase completed, spending 3 billion yuan to repurchase 2.1886 million shares.
8. Defu Technology: Plans to invest 3.1 billion yuan to build a 50,000-ton-per-year high-end AI electronic circuit copper foil project.
9. GRINM Advanced Materials: Its holding subsidiary, GRINM Yijin, is a target material supplier for Yangtze Memory Technologies and Changxin Memory Technologies.
10. Shannon Semiconductor: Expects significant revenue growth for Haipu Memory Technologies in 2026.
11. Huadian Liaoneng (3-day run, 2-day limit-up): The green hydrogen market is still in its development stage, with uncertainties in downstream demand and product prices.
12. Anhui Weixin High-Tech: Has successfully developed multiple PVB resins for electronic ceramic MLCCs and obtained customer testing approval.
13. Kanglong Chemical: Plans to invest 3 billion yuan to build a 200-ton-per-year pharmaceutical intermediate and API project.
14. Enjie Group: Plans to acquire 100% equity of Jiangsu Aisikai, with a basic purchase price of RMB 400 million.
